Table 2 Clinical and Laboratory parameters

Age (years)^a

61.5 (42–75)

Male (%)^b

42 (58%)

Female (%)^b

30 (42%)

ISS staging

 I/II/III/undetermined

18/26/23/5

 IgG/IgA/undetermined

55/12/5

 Light chain type, kappa/lambda/undetermined

42/25/5

Plasma cells in bone marrow

  < 10%

13

 10–25%

21

  > 25%

38

 Hb (g/dL)^a

9.5 (4.9–15)

 ESR (mm/h)^a

59.5 (3––150)

 Total protein (g/dL)^a

7.75 (3.44–16.7)

 Albumin (g/dL)^a

3.52 (1.1–5.2)

 Globulin (g/dL)^a

3.6 (1.43–14.43)

 Bilirubin direct (mg/dL)^a

0.13 (0.04–0.9)

 Bilirubin indirect (mg/dL)^a

0.28 (0.07–5.43)

 Bilirubin total (mg/dL)^a

0.51 (0.1–5.63)

 SGOT (U/L)^a

22.35 (2–65)

 SGPT (U/L)^a

19 (5–68)

 ALP (U/L)^a

94 (31–1136)

 Calcium (mg/dL)^a

9.05 (5.4–16.8)

 Sodium (mEq/L)^a

135 (124–142)

 Potassium (mEq/L)^a

3.4 (2.74–40.4)

 Blood urea (mg/dL)^a

31.25 (6.3–140.8)

 Uric acid (mg/dL)^a

5.75 (1.85–21.6)

 Creatinine (mg/dL)^a

1.1 (0.44–6.99)

Cytogenetic analysis

 Normal karyotype

40 (56%)

 Abnormal karyotype

28 (39%)

 Culture failure

4 (5%)